search
Back to results

Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder (ORIGAMI)

Primary Purpose

Generalized Anxiety Disorder

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Metacognitive Internet delivered Cognitive Behavior Therapy
Intolerance of uncertainty based Internet delivered Cognitive Behavior Therapy
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Generalized Anxiety Disorder focused on measuring internet delivered treatment, digital mental health services, psychiatry, cognitive behavior therapy, intolerance of uncertainty, metacognitive theory, mechanisms of change

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: 18 years or older. Meet diagnostic criteria for GAD according to DSM-5, as assessed by a psychologist on a video-call. Self-rated score > 10 on GAD-7. Can read and speak Swedish fluently. Have access to a smartphone, tablet, or computer and a Swedish BankID which allows access to the video-calls and treatment platform. Have the time and possibility to participate in the 10 week treatment. Consents to participate. Exclusion criteria: Patients that are judged to be in greater need of another psychiatric treatment for another psychiatric diagnosis (for example severe depression) and/or is judged to have a high risk of suicide. Current drug or alcohol abuse. Current severe somatic health concern or social vulnerability if this is judged to be too great an obstacle for the patient to carry out the treatment.

Sites / Locations

  • Internet Psychiatry Clinic, Psychiatry Southwest, SLSO, Region StockholmRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

IU-ICBT

Meta-ICBT

Arm Description

10 week program of internet delivered cognitive behavior therapy with written support by licensed clinical psychologist. Based on the Intolerance of uncertainty model of worry.

10 week program of internet delivered cognitive behavior therapy with written support by licensed clinical psychologist. Based on the Metacognitive model of worry.

Outcomes

Primary Outcome Measures

Change in Generalized Anxiety Disorder-7 score (GAD-7)
Measures Generalized Anxiety Symptoms. 7 items. Scores range from 0-21 with higher scores indicating more generalized anxiety
Change in Meta-Cognitions Questionnaire-30 score (MCQ-30, negative meta-cognition sub-scale)
Putative mediator. The MCQ-30 negative subscale measures negative meta-cognitive beliefs about the danger and uncontrollability of worry. 6 items. Scores range from 6-36 with higher scores indicating more negative beliefs about worry.
Change in Intolerance of Uncertainty Scale-12 score (IUS-12)
Putative mediator, measures intolerance of uncertainty. 12 items. Scores range from 12-60 with higher scores indicating more intolerance of uncertainty.

Secondary Outcome Measures

Penn-State Worry Questionnaire (PSWQ)
Measures trait worry. 16 items. Scores range from 16-80 with higher scores indicating more worry.
Contrast Avoidance Questionnaire-Worry (CAQ-W)
measures Contrast Avoidance related to worry. 25 items. Scores range from 30 to 150 with higher scores indicating a higher degree of using worry to avoid emotional contrasts.
Montomery-Asberg Depression Rating Scale - Self-rated (MADRS-S)
Measures depression symptoms. 9 items. Scores range from 0 to 54 with higher scores indicating more depressive symptoms.
Meta-Cognitions Qquestionnaire-30 (MCQ-30 - full scale)
Measures metacognition. 30 items. Scores range from 30-120 with higher scores indicating more potentially dysfunctional metacognitive beliefs about thoughts and worry.
Patient Health Questionnaire-9 (PHQ-9)
Measures depression symptoms. 9 items. Scores range from 0-27 with higher scores indicating more depressive symptoms.
World Health Organization Disability Assessment Schedule 2.0
Measures disability/functional impairment. 12 items. Scores range from 0-48 with higher scores indicating a higher degree of impairment.
Client satisfaction questionnaire (adapted to the clinic)
Measures satisfaction with treatment. 8 items. Scores range from 8-32 with higher scores indicating more satisfaction with the treatment.
Worry Behavior Inventory (WBI)
Inventory of worry behaviors - 10 items. Scores range from 0-40 with higher scores indicating more frequent worry behaviours.

Full Information

First Posted
April 4, 2023
Last Updated
September 29, 2023
Sponsor
Karolinska Institutet
Collaborators
Region Stockholm
search

1. Study Identification

Unique Protocol Identification Number
NCT05849493
Brief Title
Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder
Acronym
ORIGAMI
Official Title
Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder Based on Intolerance of Uncertainty or Metacognitive Theory
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 19, 2023 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Region Stockholm

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare two psychological treatments for Generalized Anxiety Disorder. The main questions it aims to answer are: How well do these treatments work compared to earlier studies? Is one of the treatments more effective than the other? Are the treatments working the way that we think they do? Specifically, do changes in the variables that these treatments aim to target predict changes in anxiety symptoms? Participants will be randomized to two different internet-based cognitive behavioral therapy (ICBT) programs: Intolerance of uncertainty-based ICBT and metacognition-based ICBT. Both programs consist of 8 treatment modules and run for 10 weeks. A psychologist will respond to the participants assignments and exercises and will respond to messages.
Detailed Description
A randomized trial will be conducted within the Internet Psychiatry Clinic in Stockholm. An option will be added to the online sign-up form giving potential patients the option to participate in a treatment for GAD as part of this study. Based on information provided in the sign-up-form and an assessment via video-call with a psychologist, patients will be included/excluded. Included patients will be randomized (1:1) to two different ICBT treatment programs (IU-ICBT and Meta-ICBT). These programs will be implemented into regular care at the Internet Psychiatry Clinic in Stockholm, meaning that each patient will undergo the regular assessment process at the clinic. Both programs are ICBT programs of similar scope, consisting of 8 modules to be completed during 10 weeks. During this time patients read written material which instructs them to do specific exercises, answer specific questions and can message a psychologist at the clinic via the web-platform. Based on similar treatments on the Internet Psychiatry Clinic we expect around 10% drop-out. The effectiveness of both forms of ICBT (meaning within-group change in symptoms during the ten-week treatment) will be compared to a meta-analysis of the effectiveness of traditional CBT for GAD (g = 0.80). When comparing the treatment programs to each other the threshold for a clinically relevant difference will be g = 0.24. A power analysis has shown that n=200 in each arm gives at least 80% power to detect an effect of that size. Hypothesis 1: IU-ICBT and Meta-ICBT will be effective and equivalent in a benchmarking analysis. Data-analysis: We plan to use multi-level modeling to utilize the increased power/precision we get from within-participant repeated measures. Hypothesis 2: Changes in intolerance of uncertainty will statistically mediate the treatment effect in the IU-ICBT group. Changes in negative metacognitive beliefs about worry will statistically mediate the treatment effect in the Meta-ICBT group. The effect of both mediators will be moderated by level of intolerance uncertainty and negative metacognitive beliefs at baseline. We will also compare the putative mediators to each other with the hypothesis that the mediation-effect will be stronger for the specific mediator that a treatment protocol targets. Data-analysis: Participants will fill out weekly questionnaires which will include our putative mediators (MCQ-30 and IU-12 questionnaires) and their current symptom level (GAD-7 questionnaire). The mediation-effect of both treatment protocols will be analyzed using latent growth curve modeling which is considered suitable for the study of moderation and mediation in clinical trials. Additional hypotheses: In addition to the primary hypotheses, we may also investigate alternative moderators proposed by the literature. Worry behaviors is hypothesised to moderate treatment effect in the IU-ICBT group since that treatment partially has a behavioral treatment focus. Emotional contrast avoidance will also be investigated as a moderator.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Generalized Anxiety Disorder
Keywords
internet delivered treatment, digital mental health services, psychiatry, cognitive behavior therapy, intolerance of uncertainty, metacognitive theory, mechanisms of change

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
IU-ICBT
Arm Type
Experimental
Arm Description
10 week program of internet delivered cognitive behavior therapy with written support by licensed clinical psychologist. Based on the Intolerance of uncertainty model of worry.
Arm Title
Meta-ICBT
Arm Type
Experimental
Arm Description
10 week program of internet delivered cognitive behavior therapy with written support by licensed clinical psychologist. Based on the Metacognitive model of worry.
Intervention Type
Behavioral
Intervention Name(s)
Metacognitive Internet delivered Cognitive Behavior Therapy
Intervention Description
Specialist Guided Internet delivered Cognitive Behavior Therapy based on the metacognitive model of excessive worry
Intervention Type
Behavioral
Intervention Name(s)
Intolerance of uncertainty based Internet delivered Cognitive Behavior Therapy
Intervention Description
Specialist Guided Internet delivered Cognitive Behavior Therapy based on the Intolerance of uncertainty model of excessive worry
Primary Outcome Measure Information:
Title
Change in Generalized Anxiety Disorder-7 score (GAD-7)
Description
Measures Generalized Anxiety Symptoms. 7 items. Scores range from 0-21 with higher scores indicating more generalized anxiety
Time Frame
From treatment start to 10 weeks after treatment start
Title
Change in Meta-Cognitions Questionnaire-30 score (MCQ-30, negative meta-cognition sub-scale)
Description
Putative mediator. The MCQ-30 negative subscale measures negative meta-cognitive beliefs about the danger and uncontrollability of worry. 6 items. Scores range from 6-36 with higher scores indicating more negative beliefs about worry.
Time Frame
From treatment start to 10 weeks after treatment start
Title
Change in Intolerance of Uncertainty Scale-12 score (IUS-12)
Description
Putative mediator, measures intolerance of uncertainty. 12 items. Scores range from 12-60 with higher scores indicating more intolerance of uncertainty.
Time Frame
From treatment start to 10 weeks after treatment start
Secondary Outcome Measure Information:
Title
Penn-State Worry Questionnaire (PSWQ)
Description
Measures trait worry. 16 items. Scores range from 16-80 with higher scores indicating more worry.
Time Frame
10 weeks - pre- and post-treatment.
Title
Contrast Avoidance Questionnaire-Worry (CAQ-W)
Description
measures Contrast Avoidance related to worry. 25 items. Scores range from 30 to 150 with higher scores indicating a higher degree of using worry to avoid emotional contrasts.
Time Frame
10 weeks - pre- and post-treatment.
Title
Montomery-Asberg Depression Rating Scale - Self-rated (MADRS-S)
Description
Measures depression symptoms. 9 items. Scores range from 0 to 54 with higher scores indicating more depressive symptoms.
Time Frame
10 weeks - pre- and post-treatment.
Title
Meta-Cognitions Qquestionnaire-30 (MCQ-30 - full scale)
Description
Measures metacognition. 30 items. Scores range from 30-120 with higher scores indicating more potentially dysfunctional metacognitive beliefs about thoughts and worry.
Time Frame
10 weeks - pre- and post-treatment.
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
Measures depression symptoms. 9 items. Scores range from 0-27 with higher scores indicating more depressive symptoms.
Time Frame
10 weeks - pre- and post-treatment.
Title
World Health Organization Disability Assessment Schedule 2.0
Description
Measures disability/functional impairment. 12 items. Scores range from 0-48 with higher scores indicating a higher degree of impairment.
Time Frame
10 weeks - pre- and post-treatment.
Title
Client satisfaction questionnaire (adapted to the clinic)
Description
Measures satisfaction with treatment. 8 items. Scores range from 8-32 with higher scores indicating more satisfaction with the treatment.
Time Frame
10 weeks after treatment start.
Title
Worry Behavior Inventory (WBI)
Description
Inventory of worry behaviors - 10 items. Scores range from 0-40 with higher scores indicating more frequent worry behaviours.
Time Frame
10 weeks - pre- and post-treatment.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: 18 years or older. Meet diagnostic criteria for GAD according to DSM-5, as assessed by a psychologist on a video-call. Self-rated score > 10 on GAD-7. Can read and speak Swedish fluently. Have access to a smartphone, tablet, or computer and a Swedish BankID which allows access to the video-calls and treatment platform. Have the time and possibility to participate in the 10 week treatment. Consents to participate. Exclusion criteria: Patients that are judged to be in greater need of another psychiatric treatment for another psychiatric diagnosis (for example severe depression) and/or is judged to have a high risk of suicide. Current drug or alcohol abuse. Current severe somatic health concern or social vulnerability if this is judged to be too great an obstacle for the patient to carry out the treatment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Erik Forsell, PhD
Phone
+46704903681
Email
erik.forsell@ki.se
First Name & Middle Initial & Last Name or Official Title & Degree
Vilgot Huhn, MSc
Phone
+46768482613
Email
vilgot.huhn@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erik Forsell, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Internet Psychiatry Clinic, Psychiatry Southwest, SLSO, Region Stockholm
City
Stockholm
State/Province
Huddinge
ZIP/Postal Code
14135
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erik Forsell
Phone
0704903681
Email
erik.forsell@ki.se

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Patient records not available to share.

Learn more about this trial

Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder

We'll reach out to this number within 24 hrs